SLIDESHOW: Best Dividend Stocks Analysts Like in the S&P 500
By Dividend Channel Staff, updated Wed, May 8, 11:37 AM
This Slide: #1 of 10 |
#10. Merck & Co Inc (NYSE:MRK) — Ranked #19 in the S&P by Analysts, 2.36% Dividend Yield
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s reportable segments are: the Pharmaceutical and Animal Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
|
Open the Dividend Channel MRK Page (in a new window) »
MRK Next Dividend Date » (Projection based upon history) MRK Dividend Growth Rate » Quotes delayed 20 minutes |
Strong Buy (3.82 out of 4) 75th percentile
(ranked higher than approx. 75% of all stocks covered)
Analysts' Target Price: MRK Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|